March 16, 2021 Research Bulletin

Featured Funding Opportunities

• Deadline depends on award mechanism, open  through 03/15/2023 – Agency for Healthcare Research and Quality (AHRQ), Special Emphasis Notice (SEN): Health Services Research to Address Substance Use Disorder Epidemic (NOT-HS-21-010)
  
• 04/26/2021 (for letters of intent) – Alex’s Lemonade Stand, Crazy 8 Initiative
  
• 04/30/2021 (for letters of intent) – Lung Cancer Research Foundation (LCRF), LCRF-AstraZeneca Grant Program and LCRF Pilot Grant Program
  
• 05/01/2021 – Centers for Disease Control and Prevention, Preventing Violence Affecting Young Lives (PREVAYL) (CDC-RFA-CE-21-2104)
  
• 05/03/2021 – Simons Foundation, Simons Foundation Autism Research Initiative (SFARI): Human Cognitive and Behavioral Science
  
• 05/07/2021 (for full application) – Lung Cancer Research Foundation (LCRF), LCRF Research Grant on Disparities in Lung Cancer
  
• 05/10/2021 – Office of the National Coordinator for Health Information Technology (DHHS), Leading Edge Acceleration Projects (LEAP) in Health Information Technology
  
• 05/17/2021 – Pfizer, Pre-Clinical and Translational Research in Multiple Myeloma
  
• 05/24/2021 – Patient-Centered Outcomes Research Institute (PCORI), Eugene Washington PCORI Engagement Awards – Building Capacity for PCOR-CER for Topics Related to COVID-19
  
• 06/05/2021 – National Cancer Institute, Notice of Special Interest (NOSI): Translation of Quantitative Imaging Tools and Methods for the Academic Industrial Partnership (NOT-CA-21-032)
  
• 06/11/2021 – National Heart, Lung and Blood Institute (NHLBI), Early Intervention to Promote Cardiovascular Health of Mothers and Children Multisite Clinical Centers (Collaborative UG3/UH3) (RFA-HL-22-007)
  
• 06/23/2021 – National Institute on Aging, Triadic Interactions in Clinical Encounters Involving People with Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias, Clinicians and Care Partners (R01) (RFA-AG-22-020)
  
• 06/30/2021 – National Institute of Allergy and Infectious Diseases (NIAID), Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) (RFA-AI-21-007)
  
• 07/14/2021 (first of several) – National Institutes of Health, Tobacco Regulatory Science (R01) (RFA-OD-21-002)
  
• 07/18/2021 – Human Vaccines Project, Michelson Prizes
  

NIH Funding Announcements

Limited Funding Opportunities

National Center for Advancing Translational Sciences (NCATS) has released two Requests for Applications limiting institutions to one application each. 

The purpose of the ASPIRE Collaborative Research Program is to facilitate translational and clinical research between NCATS intramural scientists and the extramural community.

New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed) (RFA-TR-21-001): 

Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed) (RFA-TR-21-002): 

• Materials due to Internal Review Committee: April 19, 2021
• Letters of Intent Due Date: June 8, 2021
• Sponsor Full Application Due Date: July 8, 2021

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format to limited.submissions@cuanschutz.edu by April 19, 2021.

National Library of Medicine has released a R01 funding opportunity titled Data Science Research: Personal Health Libraries for Consumers and Patients for novel informatics and data science approaches that can help individuals gather, manage and use data and information about their personal health.

(R01 Clinical Trial Optional)

• Materials due to Internal Review Committee: April 26, 2021
• Letter of Intent Due Date: June 30, 2021
• Sponsor Full Proposal Due Date: July 30, 2021

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format to limited.submissions@cuanschutz.edu by April 26, 2021

National Science Foundation (NSF) has released a program solicitation covering two different funding mechanisms related to the Scholarships in Science, Technology, Engineering and Mathematics (S-STEM) Network

(NSF-21-569)

1. S-STEM Resource and Evaluation Center (S-STEM REC)
2. S-STEM Research Hubs
   • Materials due to Internal Review Committee: 
     • March 22, 2021 for S-STEM REC
     • April 12, 2021 for S-STEM Research Hubs
   • Letter of Intent for S-STEM REC: April 16, 2021 (No LOI for Research Hubs)
   • Sponsor Due Date: June 16, 2021

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format to limited.submissions@cuanschutz.edu by April 16, 2021.

US Department of Energy (DOE) has released a funding opportunity titled “Materials and Chemical Sciences Research for Direct Air Capture of Carbon Dioxide”

(DE-FOA-0002481)

Institutions are limited to two pre-applications for this opportunity which are due in short order – March 30, 2021

• Materials due to Internal Review Committee: March 22, 2021
• Pre-Application Due Date: March 30, 2021
• Sponsor Full Proposal Due Date: May 18, 2021

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format to limited.submissions@cuanschutz.edu by March 22, 2021.

V Foundation has announced two funding opportunities:

V Scholar Cancer Research Program grant proposals

This call is for any area of adult cancer research focused on laboratory research that increases our understanding of cancer biology or that improves cancer detection, prevention, treatment, and survivorship. Areas not included in this scope are epidemiology, behavioral science, and health services research. The V Scholar Award supports young tenure-track faculty early in their cancer-research career by funding projects that are either laboratory-based fundamental research or translational research. The total amount of the grant is $200,000, paid in two annual installments of $100,000. Only direct costs of the research are supported by this award.

V Clinical Scholar Program

To accelerate cancer treatment and cures, the V Foundation proposes to develop the careers of clinicians who will become leaders in developing programs of clinical trials that are sequential and based on hypothesis–driven research. The competitive candidate will have a thorough knowledge of clinical trials and cancer biology as well as the ability to utilize new research discoveries for clinical intervention, the ability to develop a long-term plan to cure different forms of cancer, communicate with government agencies, and collaborate with the biotechnology and pharmaceutical industry to facilitate progress in clinical care. V Clinical Scholars will be expected to lead a program of hypothesis-driven clinical trials, initiating and completing multiple projects overseen by clinical and laboratory mentors who have a track record for conducting hypothesis-driven research with a strong translational component, often in collaboration with investigators from other disciplines. Each awardee will be expected to conduct the initial clinical trials in their designed program during the two years of the award. Trials will be based on novel pre-clinical data. Each hypothesis-driven clinical trial will include laboratory correlates that will inform the design of subsequent trials. Candidates will become familiar with the methodology, potential, and limitations of laboratory correlates. 

The total grant amount is $200,000, paid in two annual installments of $100,000. Only direct costs of the research are supported by this award. We allow flexibility in how the PI can use these funds (e.g., salary, protected time, program costs and some correlates) but it is insufficient to fund  the major costs of a clinical trial.

• Materials due to Internal Review Committee: March 31, 2021
• Sponsor Full Application Due Date: April 30, 2021

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format to limited.submissions@cuanschutz.edu by March 31, 2021.

Just Released

Fiscal Year 2021 (FY21) pre-announcements and funding opportunities for the Department of Defense (DoD) programs managed by the office of Congressionally Directed Medical Research Programs (CDMRP) are below.

FY21 Pre-announcements released:

Kidney Cancer Research Program (KCRP) 

• Academy of Kidney Cancer Investigators – Early Career Investigators Award
  
• Clinical Trial Award (NEW for FY21)
  
• Clinical Research Nurse Development Award
  
• Concept Award
  
• Idea Development Award
  
• Postdoctoral and Clinical Fellowship
  
• Translational Research Partnership Award 
  

Prostate Cancer Research Program (PCRP) 

• Data Science Award (NEW for FY21)
  
• Health Equity Research and Outcomes
  
• Improvement Consortium (HEROIC) Award (NEW for FY21)
  
• Early Investigator Research Award
  
• Physician Research Award
  
• Translational Science Award
  
• Health Disparity Research Award
  
• Idea Development Award
  
• Clinical Consortium Award
  

Special Announcements

University of Colorado Interdisciplinary Joint Biology Program

• Four one-year CUIJBP grants are available ($50,000 each) aimed to support joint biology related research.
  
• Grants will fund new initiatives for investigators who are pursuing joint-biology related research that should lead to NIH K/R type funding or other extramural support.
  

 Eligibility

• Faculty members at all ranks from the University of Colorado (all campuses) are eligible to apply as PI.
  
• Applications from early-career investigators are encouraged.
  
• Co-investigators from other institutions are also encouraged to apply, as long as a CUIJBP co-investigator is engaged in the research.

Applications are due April 1, 2021 by 5pm MST.

For more information visit the following Pilot Grants webpage or contact Dr. Larry Moreland, Director of the Interdisciplinary Joint Biology Program.

This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.   

Past Research Bulletins can be found here.

Please click here if you wish to be added to this distribution.